English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3927]
News [11438]
Articles [47]
Editorials [10]
Conferences [200]
elearning [4]
Cooperative training for medical staff in Côte d'Ivoire: The national...
Dr Chong Woo Yoo - National Cancer Center, Seoul, Republic of Korea
Cooperative training for medical staff in Côte d'Ivoire: The national radiotherapy and medical oncology center project ( Dr Chong Woo Yoo - National Cancer Center, Seoul, Republic of Korea )
24 Oct 2024
Laser oncosurgery - A new perspective in treating cancer
Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India
Laser oncosurgery - A new perspective in treating cancer ( Dr Rusy Bhalla - Orchid Center For Laser Surgery, Mumbai, India )
24 Oct 2024
Contribution of constitutional BRCA1 promoter methylation to early-onset and...
Dr Muhammad Usman Rashid - Shaukat Khanum Memorial Cancer Hospital & Research...
Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan ( Dr Muhammad Usman Rashid - Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan )
23 Oct 2024
Ethics-Guided Radiation Therapy (EGRT): A proposal to refine the practice
Dr Layth Mula-Hussain - Dalhousie University, Halifax, Canada and Ninevah...
Ethics-Guided Radiation Therapy (EGRT): A proposal to refine the practice ( Dr Layth Mula-Hussain - Dalhousie University, Halifax, Canada and Ninevah University, Ninevah, Iraq )
23 Oct 2024
Transforming cancer care in Africa: The ECHO project
Dr Daniel Osei-Fofie - Robert Mangaliso Sobukwe, Kimberley, South Africa
Transforming cancer care in Africa: The ECHO project ( Dr Daniel Osei-Fofie - Robert Mangaliso Sobukwe, Kimberley, South Africa )
23 Oct 2024
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale...
ESMO and WCLC: Latest developments in EGFR mutated NSCLC ( Dr Matthew Krebs, Dr Antonio Passaro, Dr Enriqueta Felip and Prof Pascale Tomasini )
18 Oct 2024
Predicting tumour mutations from pathology images may help increase...
Dr Rom Leidner - Providence Cancer Institute, Portland, USA
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )
17 Oct 2024
Cabozantinib demonstrates significant improvement in PFS by BICR in advanced...
Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA
Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours ( Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA )
16 Oct 2024
New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy...
Dr Li Zhang - Sun Yat-Sen University Cancer Centre, Guangzhou, China
New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients ( Dr Li Zhang - Sun Yat-Sen University Cancer Centre, Guangzhou, China )
9 Oct 2024
Tusamitamab ravtansine versus docetaxel in previously treated advanced...
Prof Benjamin Besse - Gustave Roussy, Paris, France
Tusamitamab ravtansine versus docetaxel in previously treated advanced nonsquamous NSCLC: Results from phase 3 CARMEN-LC03 trial ( Prof Benjamin Besse - Gustave Roussy, Paris, France )
1 Oct 2024
Cemiplimab monotherapy could be a new treatment option for first line advanced...
Dr Ana Baramidze - Todua Clinic, Tbilisi, Georgia
Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients ( Dr Ana Baramidze - Todua Clinic, Tbilisi, Georgia )
1 Oct 2024
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS...
Prof Salomon Manier - Hospital Center University De Lille, Lille, France
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients ( Prof Salomon Manier - Hospital Center University De Lille, Lille, France )
30 Sep 2024
<1...1213141516...328>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top